Welcome to Marit Inngjerdingen's research group: Innate Lymphocyte Group

Marit InngjerdingenGroup leader
Marit Inngjerdingen
Group leader

Our group studies innate lymphocytes, with a particular focus on how NK cells are regulated and how they can be utilized in therapy in context of allo-transplantation and hematological malignancies.


  • Developmental and functional characterization of NK cell subsets and ILCs in different tissues in the rat, and their role in acute graft versus host disease.
  • Evaluation of exosomes as early prognostic markers for risk stratification of pediatric acute leukemia.
  • In-depth mechanistic studies of how NK cells may be manipulated to target leukemia blasts using in vivo rat models of T-ALL and AML.
  • Characterization of intracellular signaling cascades in human NK cells.

Contact information:
Marit Inngjerdingen, PhD                          
Department of Pharmacology
E-mail: mariti@medisin.uio.no
Tel: +47 95 06 39 29